title: [Treatment of heart failure and preserved systolic function].
authors: Institutionen för medicin och vård, Linköpings universitet. ulf.dahlstrom@lio.se
authors: Ulf
authors: U
authors: Dahlström
authors: Kurt
authors: K
authors: Boman
authors: Lars-Ake
authors: LA
authors: Brodin
authors: Inger
authors: I
authors: Hagerman
authors: Ronnie
authors: R
authors: Willenheimer
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003971:Diastole / Q000187:drug effects / Q000502:physiology; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D013599:Systole / Q000187:drug effects / Q000502:physiology
chemical_list: D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D004232:Diuretics